Cite
Broichhausen C, Riquelme P, Ahrens N, et al. In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies. Mol Ther Methods Clin Dev. 2014;1:14026doi: 10.1038/mtm.2014.26.
Broichhausen, C., Riquelme, P., Ahrens, N., Wege, A. K., Koehl, G. E., Schlitt, H. J., Banas, B., Fändrich, F., Geissler, E. K., & Hutchinson, J. A. (2014). In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies. Molecular therapy. Methods & clinical development, 114026. https://doi.org/10.1038/mtm.2014.26
Broichhausen, Christiane, et al. "In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies." Molecular therapy. Methods & clinical development vol. 1 (2014): 14026. doi: https://doi.org/10.1038/mtm.2014.26
Broichhausen C, Riquelme P, Ahrens N, Wege AK, Koehl GE, Schlitt HJ, Banas B, Fändrich F, Geissler EK, Hutchinson JA. In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies. Mol Ther Methods Clin Dev. 2014 Jul 16;1:14026. doi: 10.1038/mtm.2014.26. eCollection 2014. PMID: 26015968; PMCID: PMC4362366.
Copy
Download .nbib